PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.

Praziquantel has been shown to be highly effective against all known species of Schistosoma infecting humans. Spherical nanoparticulate drug carriers made of poly(D,L-lactide-co-glycolide) acid with controlled size were designed. Praziquantel, a hydrophobic molecule, was entrapped into the nanoparticles with theoretical loading varying from 10 to 30% (w/w). This study investigates the effects of some process variables on the size distribution of nanoparticles prepared by emulsion-solvent evaporation method. The results show that sonication time, PLGA and drug amounts, PVA concentration, ratio between aqueous and organic phases, and the method of solvent evaporation have a significant influence on size distribution of the nanoparticles.

[1]  M. Akbarieh,et al.  Liposomal delivery system for the targeting and controlled release of praziquantel , 1992 .

[2]  Y. Kawashima,et al.  Design of rolipram-loaded nanoparticles: comparison of two preparation methods. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[3]  G. Blaschke,et al.  Investigation of praziquantel metabolism in isolated rat hepatocytes. , 2001, Journal of pharmaceutical and biomedical analysis.

[4]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[5]  S. Sahoo,et al.  Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[6]  S. Feng,et al.  Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[7]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[8]  R. Gref,et al.  Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[9]  A. Lowman,et al.  Biodegradable nanoparticles for drug delivery and targeting , 2002 .

[10]  T. Park,et al.  Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. , 1995, Biomaterials.

[11]  Hatem Fessi,et al.  Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique , 1996 .

[12]  Lisa Brannon-Peppas,et al.  Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .

[13]  J. Nah,et al.  Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. , 2000, International journal of pharmaceutics.

[14]  R. Gurny,et al.  Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. , 1998, Advanced drug delivery reviews.

[15]  H Leuenberger,et al.  Dissolution properties of praziquantel--PVP systems. , 1998, Pharmaceutica acta Helvetiae.

[16]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[17]  L. T. Webster,et al.  Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. , 1985, The Journal of infectious diseases.

[18]  M. Vert,et al.  Something new in the field of PLA/GA bioresorbable polymers? , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Ilia Fishbein,et al.  Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Sung‐Wook Choi,et al.  Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method , 2001 .

[21]  G. Becket,et al.  Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins , 1999 .

[22]  Y. Nishioka,et al.  Lymphatic targeting with nanoparticulate system. , 2001, Advanced drug delivery reviews.

[23]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[24]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[26]  T. Kissel,et al.  Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Yoshiaki,et al.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. , 1999, International journal of pharmaceutics.